VelosBio
AcquiredMerck | Home
VelosBio was founded in 2017, is headquartered in San Diego, United States, and has $195.0M in recorded funding across 2 rounds.
- Headquarters
- San Diego, California
- Founded
- 2017
- Business Model
- B2B
- Website
- velosbio.com
- Total Funding
- $195.0M
- Last Round
- $137.0M Series BJul 2020
- Rounds
- 2
- Acquired by
- Merck & Co.Dec 2020 · $2.8B
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 15 investors for this company. The full record is or through the API.
About
VelosBio was a San Diego-based clinical-stage biopharmaceutical company focused on developing first-in-class cancer therapies that targeted ROR1, a cell surface protein overexpressed in many hematologic malignancies and solid tumors. Founded in 2017, the company's lead asset VLS-101 was an antibody-drug conjugate (ADC) that demonstrated compelling early clinical data across multiple tumor types. VelosBio raised a $137 million Series B round in 2020 before being acquired by Merck for $2.75 billion later that year, validating the ROR1 targeting approach as a promising oncology strategy.
Summary
VelosBio is a Biotech company based in San Diego, United States, founded in 2017. It has raised $195.0M in total across 2 rounds, most recently a $137.0M Series B round in Jul 2020. Investors include Merck Life Sciences, Matrix Capital Management and Surveyor Capital.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Dec 2020
Sign up to see all 3 events
Funding: Series A through Series B. Amounts, valuations, and investors where available.
Investors
Merck Life Sciences
1 round
Matrix Capital Management
1 round
Surveyor Capital
1 round
Arix Bioscience
1 round
Pappas Capital
1 round
Adage Capital
1 round
Cormorant Asset Management
1 round
Farallon Capital
1 round
Foresite Capital
1 round
Viking Global
1 round
Janus Henderson Investors
1 round
Decheng Capital
1 round
Sofinnova Investments
1 round
Takeda (JP)
1 round
Chiesi Ventures
1 round
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/velosbio"><img src="https://indexed.vc/api/badge/company/velosbio" alt="VelosBio on Indexed.vc" width="260" height="76" /></a>